AbCellera shares jump 15.83% as FDA approves Jazz cancer regimens

Verifying

verifying reliability

The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.
AbCellera shares jump 15.83% as FDA approves Jazz cancer regimens - CoinPost Terminal